Combogesic IV 3 mg (Ibuprofen (Ibuprofen Sodium Dihydrate) SOLUTION) 3 MG

Combogesic IV 3 mg is an intravenous solution containing ibuprofen sodium dihydrate. It is commonly used for pain relief and reducing inflammation. This medication is manufactured by AFT Pharmaceuticals in Canada.

Strength

3 MG

Manufacturer / TM Owner

AFT PHARMACEUTICALS (CAN) LIMITED

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Combogesic IV 3 mg is primarily used for managing pain and inflammation. It is administered intravenously, making it suitable for situations where oral administration is not feasible. This solution is often utilized in clinical settings for its rapid onset of action.

Side Effects

Combogesic IV 3 mg may cause common side effects such as nausea, vomiting, and dizziness. Some individuals might experience mild to moderate pain at the injection site. Always consult a healthcare provider for personalized advice.

Precautions & Warnings

Combogesic IV 3 mg should be handled with care, ensuring proper sterile techniques during administration. It is important to monitor for any signs of allergic reactions or adverse effects. This medication should be used under medical supervision.

Avoid Interactions

Combogesic IV 3 mg may interact with other medications, including blood thinners and certain pain relievers. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be avoided while using this medication.

Frequently Asked Questions

Combogesic IV 3 mg is used for pain relief and reducing inflammation, typically administered intravenously in clinical settings.

Combogesic IV 3 mg is administered intravenously by healthcare professionals, ensuring proper sterile techniques.

Common side effects may include nausea, vomiting, dizziness, and mild to moderate pain at the injection site.

Combogesic IV 3 mg may interact with other medications, so it is important to consult a healthcare provider before combining it with other treatments.

Combogesic IV 3 mg should be used under medical supervision, as it may not be suitable for everyone, especially those with certain medical conditions or allergies.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.